FDA Approves 1st New Drug for ALS in Decades

MONDAY, May 8, 2017 — The first new drug to treat amyotrophic lateral sclerosis (ALS) in more than 20 years has been approved by the U.S. Food and Drug Administration.
Radicava (edaravone) is taken intravenously daily for 14 days, followed by 14…
Source: Topamax